Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 3
1964 3
1965 3
1966 7
1967 4
1968 1
1969 6
1970 5
1971 5
1972 4
1973 6
1974 5
1975 7
1976 6
1977 12
1978 11
1979 9
1980 9
1981 8
1982 11
1983 12
1984 14
1985 22
1986 16
1987 26
1988 36
1989 44
1990 43
1991 58
1992 60
1993 91
1994 92
1995 97
1996 125
1997 112
1998 130
1999 135
2000 160
2001 189
2002 209
2003 274
2004 245
2005 247
2006 253
2007 246
2008 247
2009 217
2010 223
2011 280
2012 238
2013 250
2014 217
2015 251
2016 240
2017 217
2018 209
2019 211
2020 228
2021 239
2022 220
2023 196
2024 92

Text availability

Article attribute

Article type

Publication date

Search Results

6,202 results

Results by year

Filters applied: . Clear all
Page 1
Chimerism-based Tolerance Induction in Clinical Transplantation: Its Foundations and Mechanisms.
Mengrelis K, Muckenhuber M, Wekerle T. Mengrelis K, et al. Transplantation. 2023 Dec 1;107(12):2473-2485. doi: 10.1097/TP.0000000000004589. Epub 2023 Apr 13. Transplantation. 2023. PMID: 37046378 Review.
Hematopoietic chimerism remains the most promising strategy to bring transplantation tolerance into clinical routine. ...For this to be successful, donor hematopoietic cells need to engraft in the recipient at least temporarily. Three pioneering clinical trials indu …
Hematopoietic chimerism remains the most promising strategy to bring transplantation tolerance into clinical routine. ...For t …
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.
Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, Burroughs LM, Majhail N, Al-Homsi AS, Al-Kadhimi ZS, Bar M, Bertaina A, Boelens JJ, Champlin R, Chaudhury S, DeFilipp Z, Dholaria B, El-Jawahri A, Fanning S, Fraint E, Gergis U, Giralt S, Hamilton BK, Hashmi SK, Horn B, Inamoto Y, Jacobsohn DA, Jain T, Johnston L, Kanate AS, Kansagra A, Kassim A, Kean LS, Kitko CL, Knight-Perry J, Kurtzberg J, Liu H, MacMillan ML, Mahmoudjafari Z, Mielcarek M, Mohty M, Nagler A, Nemecek E, Olson TS, Oran B, Perales MA, Prockop SE, Pulsipher MA, Pusic I, Riches ML, Rodriguez C, Romee R, Rondon G, Saad A, Shah N, Shaw PJ, Shenoy S, Sierra J, Talano J, Verneris MR, Veys P, Wagner JE, Savani BN, Hamadani M, Carpenter PA. Kharfan-Dabaja MA, et al. Transplant Cell Ther. 2021 Aug;27(8):642-649. doi: 10.1016/j.jtct.2021.04.007. Transplant Cell Ther. 2021. PMID: 34304802 Free article.
Allogeneic hematopoietic cell transplantation (allo-HCT) is potentially curative for certain hematologic malignancies and nonmalignant diseases. ...To address these contemporary challenges, we surveyed a panel of allo-HCT experts in an attempt to standardize these definiti …
Allogeneic hematopoietic cell transplantation (allo-HCT) is potentially curative for certain hematologic malignancies and nonmalignan …
Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation.
Pathak S, Meyer EH. Pathak S, et al. Front Immunol. 2021 Jan 29;11:612737. doi: 10.3389/fimmu.2020.612737. eCollection 2020. Front Immunol. 2021. PMID: 33658995 Free PMC article. Review.
However, long-term treatment with immunosuppressive drugs (ISDs) remains essential for islet graft survival. Current ISD regimens carry significant side-effects for transplant recipients, and are also toxic to the transplanted islets. ...Here, we review preclinical …
However, long-term treatment with immunosuppressive drugs (ISDs) remains essential for islet graft survival. Current ISD regimens carry sign …
Role of HLA typing and chimerism analysis in post-liver transplantation GVHD in pediatrics: A systematic review.
Ghandorah S, Alsawaf B, Alrefai W, Ghazwani A, Almusabi S. Ghandorah S, et al. Pediatr Transplant. 2022 Dec;26(8):e14381. doi: 10.1111/petr.14381. Epub 2022 Aug 18. Pediatr Transplant. 2022. PMID: 35979882 Review.
RESULTS: A total of 18 articles reported 21 cases of GVHD after liver transplantation in pediatrics. Generally, there is a consensus on the advantage of HLA typing and chimerism analysis in confirming the diagnosis of GVHD after liver transplantation. ...This …
RESULTS: A total of 18 articles reported 21 cases of GVHD after liver transplantation in pediatrics. Generally, there is a consensus …
Combined kidney and hematopoeitic cell transplantation to induce mixed chimerism and tolerance.
Lowsky R, Strober S. Lowsky R, et al. Bone Marrow Transplant. 2019 Aug;54(Suppl 2):793-797. doi: 10.1038/s41409-019-0603-4. Bone Marrow Transplant. 2019. PMID: 31431706 Free PMC article. Review.
Tolerance, persistent mixed chimerism, and complete withdrawal was achieved in the majority of fully matched patients. Persistent mixed chimerism and partial withdrawal has been achieved in the haplotype matched patients at present....
Tolerance, persistent mixed chimerism, and complete withdrawal was achieved in the majority of fully matched patients. Persistent mix …
Chimerism Testing by Next Generation Sequencing for Detection of Engraftment and Early Disease Relapse in Allogeneic Hematopoietic Cell Transplantation and an Overview of NGS Chimerism Studies.
Liacini A, Tripathi G, McCollick A, Gravante C, Abdelmessieh P, Shestovska Y, Mathew L, Geier S. Liacini A, et al. Int J Mol Sci. 2023 Jul 23;24(14):11814. doi: 10.3390/ijms241411814. Int J Mol Sci. 2023. PMID: 37511573 Free PMC article. Review.
Chimerism monitoring after allogenic Hematopoietic Cell Transplantation (allo-HCT) is critical to determine how well donor cells have engrafted and to detect relapse for early therapeutic intervention. ...The accuracy and linearity of the assays were evaluated in 46 …
Chimerism monitoring after allogenic Hematopoietic Cell Transplantation (allo-HCT) is critical to determine how well donor cel …
Chimerism analysis for clinicians: a review of the literature and worldwide practices.
Blouin AG, Askar M. Blouin AG, et al. Bone Marrow Transplant. 2022 Mar;57(3):347-359. doi: 10.1038/s41409-022-01579-9. Epub 2022 Jan 26. Bone Marrow Transplant. 2022. PMID: 35082369 Free PMC article. Review.
This review highlights literature pertinent to chimerism analysis in the context of hematopoietic cell transplantation (HCT). ...Lineage specific chimerism is more sensitive than whole blood in predicting impending relapse. ...
This review highlights literature pertinent to chimerism analysis in the context of hematopoietic cell transplantation (HCT). …
Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease.
Chu Y, Talano JA, Baxter-Lowe LA, Verbsky JW, Morris E, Mahanti H, Ayello J, Keever-Taylor C, Johnson B, Weinberg RS, Shi Q, Moore TB, Fabricatore S, Grossman B, van de Ven C, Shenoy S, Cairo MS. Chu Y, et al. Front Immunol. 2022 Dec 9;13:1055497. doi: 10.3389/fimmu.2022.1055497. eCollection 2022. Front Immunol. 2022. PMID: 36569951 Free PMC article.
Pre-transplant HLA antibodies were characterized. Donor chimerism was monitored 1-24 months post-transplant. ...Activated CD4 and CD8 T-cells were elevated at 100-365 days post-transplant while naive cells remained below baseline. Tregs were elevated a …
Pre-transplant HLA antibodies were characterized. Donor chimerism was monitored 1-24 months post-transplant. ...Activat …
Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature.
Delie A, Verlinden A, Beel K, Deeren D, Mazure D, Baron F, Breems D, De Becker A, Graux C, Lewalle P, Maertens J, Poire X, Schoemans H, Selleslag D, Van Obbergh F, Kerre T. Delie A, et al. Acta Clin Belg. 2021 Dec;76(6):500-508. doi: 10.1080/17843286.2020.1754635. Epub 2020 May 2. Acta Clin Belg. 2021. PMID: 32362204 Free article. Review.
Chimerism analysis, which determines the donor or recipient origin of hematopoietic cells in HSCT recipients, is an essential aspect of post-HSCT follow-up.Objectives: To review the current literature and develop Belgian consensus guidelines for the use of chimerism …
Chimerism analysis, which determines the donor or recipient origin of hematopoietic cells in HSCT recipients, is an essential aspect …
Chimerism and bone marrow based therapies in transplantation.
Siemionow M, Nasir S. Siemionow M, et al. Microsurgery. 2007;27(5):510-21. doi: 10.1002/micr.20395. Microsurgery. 2007. PMID: 17596895 Review.
Composite tissue allotransplantation holds a great potential for providing increased knowledge of anatomy and microsurgical experience for life-enhancing reconstructions. Many transplant cases around the world have made this a clinical reality at the present time. ...In th …
Composite tissue allotransplantation holds a great potential for providing increased knowledge of anatomy and microsurgical experience for l …
6,202 results